iifl-logo-icon 1

Kopran Ltd Share Price

248.3
(-2.13%)
Jul 18, 2024|03:32:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open253.65
  • Day's High254.65
  • 52 Wk High292.3
  • Prev. Close253.7
  • Day's Low246.1
  • 52 Wk Low159.7
  • Turnover (lac)530.65
  • P/E35.31
  • Face Value10
  • Book Value89.24
  • EPS7.18
  • Mkt. Cap (Cr.)1,197.07
  • Div. Yield1.18
No Records Found

Kopran Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

253.65

Prev. Close

253.7

Turnover(Lac.)

530.65

Day's High

254.65

Day's Low

246.1

52 Week's High

292.3

52 Week's Low

159.7

Book Value

89.24

Face Value

10

Mkt Cap (₹ Cr.)

1,197.07

P/E

35.31

EPS

7.18

Divi. Yield

1.18

Kopran Ltd Corporate Action

8 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

25 May 2023

12:00 AM

Dividend

Dividend Amount: 3

arrow

17 Aug 2023

12:00 AM

BookCloser

arrow

17 Aug 2023

12:00 AM

AGM

Announcement Date: 17 Aug, 2023

arrow

Kopran Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Kopran Ltd SHAREHOLDING SNAPSHOT

18 Jul, 2024|11:39 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 44.49%

Foreign: 0.00%

Indian: 44.49%

Non-Promoter- 0.82%

Institutions: 0.81%

Non-Institutions: 54.69%

Custodian: 0.00%

Share Price

Kopran Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

48.21

48.21

43.25

43.25

Preference Capital

0

0

0

0

Reserves

347.38

330.51

203.6

186.42

Net Worth

395.59

378.72

246.85

229.67

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

204.52

222.83

179.29

153.69

yoy growth (%)

-8.21

24.28

16.65

-15.33

Raw materials

-127.82

-137.74

-101.16

-91.24

As % of sales

62.5

61.81

56.42

59.36

Employee costs

-21.05

-18.33

-20.02

-18.33

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

16.16

32.7

15.73

6.96

Depreciation

-4.32

-4.1

-3.47

-3.22

Tax paid

-4.42

-9.23

-4.51

-2.25

Working capital

53.98

-10.52

14.2

-0.58

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-8.21

24.28

16.65

-15.33

Op profit growth

-48.96

30.3

158.76

-48.38

EBIT growth

-47.64

68.3

59.58

-41.25

Net profit growth

-49.96

109.2

138.37

-44.65

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

614.59

550.99

477.52

491.81

359.5

Excise Duty

0

0

0

0

0

Net Sales

614.59

550.99

477.52

491.81

359.5

Other Operating Income

0

0

0

0

0

Other Income

14.61

3.07

10.6

17.99

0.63

Kopran Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,579.3

124.153,78,914.98867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,510.4

32.861,22,044.231,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,570.8

76.931,21,185.085310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,184.8

34.691,19,223.631,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,646.05

25.871,10,827.471,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Kopran Ltd

Management

Register Office

Registrar Office

Executive Vice Chairman

Surendra Somani

Company Sec. & Compli. Officer

Sunil Sodhani

Independent Director

Siddhan Subramanian

Independent Director

Sunita Banerji

Independent Director

Mamta Biyani

Independent Director

Narayan Atal

Chairman (Non-Executive)

Susheel Somani

Non Executive Director

Adarsh Somani

Non Executive Director

Varun Somani

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Kopran Ltd., incorporated on April 26, 1958, was promoted by the Somani group and is controlled by Parijat Enterprises. The company came out with a public issue at a premium, in Nov.92, to finance its backward integration project to produce drug intermediates for semi-synthetic drugs, and also to expand its antibiotic facility.Kopran manufactures pharmaceutical finished dosage forms and bulk drugs and distributes electronic equipment. It manufactures semi-synthetic penicillin and is among the worlds highest producers in amoxycillin. Kopran also makes penicillin-G acylase, an enzyme made through fermentation. It has technical collaborations with Gesellschaft Fur Biotechnologische, Germany; Yuhan Corporation, South Korea; Ciba Corning Diagnostic, US; and Adac Laboratories, US.Koprans bulk drug plant has been approved by the US FDA and the UK regulatory authorities. In 1995, the company was awarded the Quality Excellence award by the Indian Drug Manufacturers Association. Koprans high growth rate in exports has been recognised by a number of awards from CHEMEXCIL and the Ministry of Commerce.The company launched new products like AZ-1 Caps, Klodip Tabs, Moclox Kid Tabs, Amyn Kid Tabs, Tini-NF, Amyn Caps and Amyn Dry Syrup. Kopran entered into a joint venture with M/s Industrial Promotion Services Ltd to take over a running unit viz Kampala Pharmaceuticals Industries Ltd in Uganda.The company has been ranked as amongst the top few fastest growing companies in India(ORG Marg-June
Read More

Company FAQs

What is the Kopran Ltd share price today?

Down Arrow

The Kopran Ltd shares price on N/A is Rs.₹248.75 today.

What is the Market Cap of Kopran Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Kopran Ltd is ₹1199.24 Cr. as of 18 Jul ‘24

What is the PE and PB ratio of Kopran Ltd?

Down Arrow

The PE and PB ratios of Kopran Ltd is 35.31 and 2.93 as of 18 Jul ‘24

What is the 52 Week High and Low of Kopran Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Kopran Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Kopran Ltd is ₹160 and ₹292.4 as of 18 Jul ‘24

What is the CAGR of Kopran Ltd?

Down Arrow

Kopran Ltd's CAGR for 5 Years at 47.51%, 3 Years at 3.27%, 1 Year at 41.77%, 6 Month at -4.23%, 3 Month at -5.00% and 1 Month at -0.76%.

What is the shareholding pattern of Kopran Ltd?

Down Arrow

The shareholding pattern of Kopran Ltd is as follows:
Promoters - 44.49 %
Institutions - 0.81 %
Public - 54.70 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.